Get startedLog in
    Picture of Mezzion Pharma logo

    140410 — Mezzion Pharma News Story

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Mezzion Announces Submission Of NDA For Its Orphan Drug Udenafil

    Picture of Mezzion Pharma logoMezzion Pharma
    30/06/2020 17:49
    June 30 (Reuters) - Mezzion Pharma Co Ltd  140410.KQ :
    * MEZZION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR
ITS
ORPHAN DRUG UDENAFIL TO TREAT PATIENTS WHO HAVE UNDERGONE THE
FONTAN OPERATION FOR SINGLE VENTRICLE HEART DISEASE

Source text for Eikon:  ID:nPnc31gwfa 
Further company coverage:  140410.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Mezzion Pharma

    See all news